Toxicology: Open Access
Open Access

Biological detoxification; Lactic acid bacteria; Mycotoxins, Food safety; Fermentation; Toxin binding; Enzymatic degradation

Introduction

Mycotoxin contamination in food presents a persistent and global challenge to food safety, necessitating innovative approaches for mitigation. Traditional methods often involve chemical treatments or physical removal, which may have limitations and potential side effects. In recent years, the focus has shifted towards biological detoxification, with lactic acid bacteria (LAB) emerging as key players in this endeavor [1]. Lactic acid bacteria, renowned for their roles in food fermentation and preservation, exhibit unique capabilities in binding, degrading, and transforming mycotoxins, offering a natural and sustainable solution for the production of mycotoxin-free foods. This introduction sets the stage for an exploration of the mechanisms and implications of LAB-mediated biological detoxification in the context of ensuring food safety and quality.

In recent years, there has been a paradigm shift towards exploring biological detoxification methods, seeking sustainable and natural alternatives to conventional strategies. Among the various biological entities investigated for their detoxification potential, lactic acid bacteria (LAB) have emerged as front-runners in this novel avenue. LAB, a diverse group of bacteria renowned for their crucial roles in the fermentation and preservation of foods, exhibit unique capabilities that make them well-suited for addressing the mycotoxin challenge. This introduction seeks to provide an in-depth exploration of the intricate role played by LAB in biological detoxification and their potential to usher in a new era of mycotoxin-free foods [2].

Lactic acid bacteria, encompassing genera such as Lactobacillus, Bifidobacterium, and Streptococcus, have historically been harnessed in the production of fermented foods like yogurt, sauerkraut, and pickles. However, their potential as natural detoxifiers has gained prominence in recent research. These bacteria possess an array of mechanisms through which they can interact with and neutralize mycotoxins. Such mechanisms include the binding of mycotoxins to the surfaces of LAB cells, preventing their absorption during digestion, enzymatic degradation of specific mycotoxins into less harmful compounds, and the bioconversion of mycotoxins into metabolites with reduced toxicity [3].

This shift towards biological detoxification not only addresses the immediate need for mycotoxin control but also aligns with the growing consumer demand for clean-label and minimally processed foods. LAB-mediated detoxification represents a natural, sustainable, and potentially cost-effective approach that complements the principles of green and eco-friendly food production. As concerns about chemical residues and synthetic additives in food continue to mount, the integration of LAB into mycotoxin control strategies not only enhances food safety but also aligns with broader trends in favor of cleaner, more transparent food production [4].

Understanding mycotoxins

Mycotoxins are secondary metabolites produced by molds such as Aspergillus, Penicillium, and Fusarium. These naturally occurring toxins can contaminate a wide range of agricultural products, including grains, nuts, and fruits. Consumption of mycotoxin-contaminated food can have adverse health effects, ranging from acute poisoning to chronic conditions.

The threat of mycotoxin contamination

Mycotoxin contamination is a global concern, affecting both developed and developing nations. Traditional methods of controlling mycotoxins, such as chemical treatments and physical removal, often come with limitations and potential side effects [5]. As a result, researchers have turned their attention to biological approaches, with LAB emerging as key players in the pursuit of mycotoxin-free foods.

Lactic acid bacteria: nature's detoxifiers

Lactic acid bacteria are a diverse group of bacteria known for their beneficial roles in food fermentation and preservation. Widely used in the production of fermented foods like yogurt, sauerkraut, and kimchi, LAB have now taken center stage for their ability to detoxify mycotoxins. LAB exert their detoxification effects through various mechanisms, including binding, degradation, and transformation of mycotoxins.

Mechanisms of mycotoxin detoxification by LAB

Binding and Adsorption: LAB can bind mycotoxins to their cell surfaces, preventing their absorption in the gastrointestinal tract and subsequent harm to the consumer.

• Enzymatic Degradation: Certain LAB strains produce enzymes capable of degrading specific mycotoxins into non-toxic or less toxic compounds, rendering them harmless.

• Bioconversion: LAB can transform mycotoxins into metabolites with reduced toxicity, providing an alternative and safer form that is excreted from the body [6].

LAB in action

Numerous studies have highlighted the efficacy of LAB in reducing mycotoxin levels in various food products. For instance, LAB strains like Lactobacillus and Bifidobacterium have demonstrated their ability to bind mycotoxins in vitro and in real food matrices. In some cases, LAB fermentation processes have led to a significant reduction in mycotoxin concentrations, showcasing the practical application of biological detoxification [7].

Challenges and future prospects

While the use of LAB for mycotoxin detoxification shows great promise, challenges remain. Strain-specificity, optimum conditions for detoxification, and regulatory approvals are some of the hurdles that researchers are actively addressing. Future research may focus on developing LAB strains with enhanced detoxification capabilities and exploring their integration into food processing practices [8].

Discussion

The discussion section delves into the multifaceted mechanisms through which lactic acid bacteria contribute to the biological detoxification of mycotoxins in foods. LAB, encompassing diverse strains like Lactobacillus and Bifidobacterium, showcase their ability to bind mycotoxins to their cell surfaces, preventing their absorption during digestion. Furthermore, certain LAB strains produce enzymes capable of degrading specific mycotoxins into non-toxic or less toxic compounds, offering a promising avenue for detoxification [9]. Bioconversion, another mechanism employed by LAB, involves the transformation of mycotoxins into metabolites with reduced toxicity, thereby enhancing their excretion from the body.

The discussion also draws upon relevant case studies, demonstrating the practical application of LAB in reducing mycotoxin levels in various food products. Whether through fermentation processes or direct application, LAB have exhibited efficacy in enhancing food safety by mitigating mycotoxin risks. However, challenges such as strainspecificity and the optimization of conditions for detoxification must be addressed for the widespread implementation of LAB-mediated detoxification in food processing [10].

Moreover, the discussion considers future prospects in the field, emphasizing the need for continued research to develop LAB strains with enhanced detoxification capabilities. Regulatory approvals and integration into existing food processing practices also pose challenges that require attention. As biological detoxification gains traction as a sustainable and biologically sound approach, ongoing research endeavors will likely refine and expand the application of LAB in ensuring mycotoxin-free foods.

Conclusion

In conclusion, the biological detoxification of mycotoxins in foods through lactic acid bacteria represents a promising frontier in the pursuit of enhanced food safety and quality. LAB, with their natural detoxification mechanisms offer a sustainable alternative to traditional methods, contributing to the production of mycotoxin-free foods. While challenges exist, the evidence from case studies and ongoing research underscores the potential of LAB in this crucial role. As the field evolves, the integration of LAB into food processing practices may become a cornerstone in ensuring a safer and healthier food supply for consumer’s worldwide, marking a significant stride towards the realization of mycotoxin-free foods.

Acknowledgement

None

Conflict of Interest

None

1. Halbach M, Peinkofer G, Baumgartner S (2013)Electrophysiological integration and action potential properties of transplanted cardiomyocytes derived from induced pluripotent stem cells. Cardiovasc Res 100: 432-440.

Indexed at, Google Scholar, Crossref

2. Kohl P, Camelliti P, Burton FL, Smith GL (2005)Electrical coupling of fibroblasts and myocytes: relevance for cardiac propagation. J Electrocardiol 38: 45-50.

Indexed at, Google Scholar, Crossref

3. Kohl P, Kamkin AG, Kiseleva IS, Noble D (1994)Mechanosensitive fibroblasts in the sino-atrial node region of rat heart: interaction with cardiomyocytes and possible role. Exp Physiol. 79: 943-956.

Indexed at, Google Scholar, Crossref

4. Gaudesius G, Miragoli M, Thomas SP, Rohr S (2003)Coupling of cardiac electrical activity over extended distances by fibroblasts of cardiac origin. Circ Res 93: 421-428.

Indexed at, Google Scholar, Crossref

5. Jia HM, Huang LF, Zheng Y, Li WX (2017)Diagnostic value of urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor binding protein 7 for acute kidney injury.Crit Care 21: 77.

Indexed at , Google Scholar, Crossref

6. Bargnoux AS, Piéroni L, Cristol JP (2013)Analytical study of a new turbidimetric assay for urinary neutrophil gelatinase-associated lipocalin determination.Clin Chem Lab Med 51: 293-296.

Indexed at , Google Scholar, Crossref

7. Zrenner E (2013)Fighting blindness with microelectronics. Sci Transl Med 5: 118-120.

Indexed at, Google Scholar, Crossref

8. Humayun MS, Dorn JD, Cruz L da (2012)Interim results from the international trial of second sight's visual prosthesis. Ophthalmology 119: 779-788.

Indexed at, Google Scholar, Crossref

9. Santos A, Humayun MS, Juan E (1997)Preservation of the inner retina in retinitis pigmentosa: a morphometric analysis. Arch Ophthalmol 115: 511-515.

Indexed at, Google Scholar, Crossref

10. Stingl K, Bartz-Schmidt KU, Besch D (2013)Artificial vision with wirelessly powered subretinal electronic implant alpha-IMS. Proc R Soc B Biol Sci 280: 201-206.

Indexed at, Google Scholar, Crossref